CID 16073756
3-quinolinecarboxylic acid, 5-amino-7-[4-[(5-amino-1,3,4-thiadiazol-2-yl)sulfonyl]-3,5-dimethyl-1-piperazinyl]-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-
Structural Information
- Molecular Formula
- C21H24FN7O5S2
- SMILES
- CC1CN(CC(N1S(=O)(=O)C2=NN=C(S2)N)C)C3=C(C(=C4C(=C3)N(C=C(C4=O)C(=O)O)C5CC5)N)F
- InChI
- InChI=1S/C21H24FN7O5S2/c1-9-6-27(7-10(2)29(9)36(33,34)21-26-25-20(24)35-21)14-5-13-15(17(23)16(14)22)18(30)12(19(31)32)8-28(13)11-3-4-11/h5,8-11H,3-4,6-7,23H2,1-2H3,(H2,24,25)(H,31,32)
- InChIKey
- VZVPRZJOAWWAAQ-UHFFFAOYSA-N
- Compound name
- 5-amino-7-[4-[(5-amino-1,3,4-thiadiazol-2-yl)sulfonyl]-3,5-dimethylpiperazin-1-yl]-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid
- Related CIDs
2D Structure
Profile
Predicted Collision Cross Section
Adduct | m/z | Predicted CCS (Ų) |
---|---|---|
[M+H]+ | 538.13374 | 221.7 |
[M+Na]+ | 560.11568 | 232.2 |
[M-H]- | 536.11918 | 226.0 |
[M+NH4]+ | 555.16028 | 218.6 |
[M+K]+ | 576.08962 | 221.2 |
[M+H-H2O]+ | 520.12372 | 215.1 |
[M+HCOO]- | 582.12466 | 224.2 |
[M+CH3COO]- | 596.14031 | 226.2 |
[M+Na-2H]- | 558.10113 | 218.0 |
[M]+ | 537.12591 | 225.5 |
[M]- | 537.12701 | 225.5 |
Literature stripe
Patent stripe
No patent data available for this compound.